Apyx Medical Corporation (APYX)
NASDAQ: APYX · IEX Real-Time Price · USD
1.420
+0.020 (1.43%)
At close: May 2, 2024, 4:00 PM
1.380
-0.040 (-2.82%)
After-hours: May 2, 2024, 4:56 PM EDT
Apyx Medical Revenue
In the year 2023, Apyx Medical had annual revenue of $52.35M with 17.61% growth. Revenue in the quarter ending December 31, 2023 was $14.66M with 16.26% year-over-year growth.
Revenue (ttm)
$52.35M
Revenue Growth
+17.61%
P/S Ratio
0.95
Revenue / Employee
$207,734
Employees
252
Market Cap
49.19M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 52.35M | 7.84M | 17.61% |
Dec 31, 2022 | 44.51M | -4.01M | -8.26% |
Dec 31, 2021 | 48.52M | 20.81M | 75.08% |
Dec 31, 2020 | 27.71M | -524.00K | -1.86% |
Dec 31, 2019 | 28.24M | 11.63M | 70.04% |
Dec 31, 2018 | 16.61M | 6.37M | 62.25% |
Dec 31, 2017 | 10.23M | 1.42M | 16.04% |
Dec 31, 2016 | 8.82M | -20.70M | -70.13% |
Dec 31, 2015 | 29.52M | 1.84M | 6.64% |
Dec 31, 2014 | 27.68M | 4.02M | 16.99% |
Dec 31, 2013 | 23.66M | -4.01M | -14.50% |
Dec 31, 2012 | 27.67M | 2.26M | 8.89% |
Dec 31, 2011 | 25.41M | 1.18M | 4.87% |
Dec 31, 2010 | 24.23M | -2.72M | -10.10% |
Dec 31, 2009 | 26.95M | -1.14M | -4.07% |
Dec 31, 2008 | 28.10M | -682.16K | -2.37% |
Dec 31, 2007 | 28.78M | 2.10M | 7.88% |
Dec 31, 2006 | 26.68M | 6.47M | 31.99% |
Dec 31, 2005 | 20.21M | -283.96K | -1.39% |
Dec 31, 2004 | 20.50M | 4.38M | 27.16% |
Dec 31, 2003 | 16.12M | 3.67M | 29.50% |
Dec 31, 2002 | 12.45M | 913.76K | 7.92% |
Dec 31, 2001 | 11.53M | 1.60M | 16.07% |
Dec 31, 2000 | 9.94M | 243.17K | 2.51% |
Dec 31, 1999 | 9.69M | 1.25M | 14.82% |
Dec 31, 1998 | 8.44M | 1.07M | 14.52% |
Dec 31, 1997 | 7.37M | -114.62K | -1.53% |
Dec 31, 1996 | 7.49M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cutera | 230.18M |
Nortech Systems | 139.33M |
IRIDEX | 51.87M |
Daxor | 34.67M |
Milestone Scientific | 9.83M |
Gain Therapeutics | 55.18K |
APYX News
- 7 days ago - Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024 - Business Wire
- 21 days ago - Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit - Business Wire
- 6 weeks ago - Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook - Business Wire
- 2 months ago - Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024 - Business Wire
- 2 months ago - Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting - Business Wire
- 3 months ago - Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body - Business Wire
- 4 months ago - Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results - Business Wire
- 5 months ago - Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer - Business Wire